How should ACE inhibitors (angiotensin‑converting enzyme inhibitors) or ARBs (angiotensin receptor blockers) be initiated and dosed in patients with chronic kidney disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the role of Angiotensin Receptor Blockers (ARBs) and Angiotensin-Converting Enzyme inhibitors (ACE inhibitors) in patients with Chronic Kidney Disease (CKD) stage 5?
What is the diagnosis for a 72-year-old man with hyperglycemia, uncontrolled hypertension, diabetic retinopathy, and proteinuria?
What does not describe a change in the 'perpetuating process' stage of Chronic Kidney Disease (CKD) - early, accelerated nephrosclerosis, glomerular filtration membrane changes, increased vasoconstriction, or hypertrophy of nephrons?
What are the recommended antihypertensive (blood pressure medication) doses for patients with Chronic Kidney Disease (CKD) based on estimated Glomerular Filtration Rate (eGFR)?
What are the implications of Chronic Kidney Disease stage 3 (CKD3) with impaired renal function?
What is the appropriate management for eczema of the areola?
Can a gallbladder contain gallstones despite a negative CT scan?
What is the mechanism of action of berberine?
A patient prescribed 90 mg of Adderall (mixed d‑amphetamine and l‑amphetamine) who is an ultra‑rapid metabolizer has a urine drug screen positive for methamphetamine; how does the laboratory differentiate prescribed amphetamine from illicit methamphetamine?
What is the recommended evaluation and management for a 50-year-old man with fatigue, elevated ferritin, and a 4 cm × 6 cm subcapsular hypoechoic lesion in the posterior left hepatic lobe?
In a patient with distal burning pain, numbness, paresthesias, gait instability, spasticity, a positive Babinski sign, and bowel/bladder dysfunction, could chronic inflammatory demyelinating polyneuropathy (CIDP) be the primary diagnosis, or should it be considered only as a possible coexisting peripheral neuropathy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.